Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Light Therapy Could Treat Vascular Constriction Diseases

By HospiMedica International staff writers
Posted on 30 Nov 2014
A new study describes a receptor on blood vessels that cause them to relax in response to light, making it potentially useful in treating vascular diseases. More...


Researchers at Johns Hopkins University (JHU; Baltimore, MD, USA) used polymerase chain reaction (PCR) to demonstrate that melanopisn (Opn4, a member of a group of non-image-forming light receptors) is expressed in blood vessels in mice via a photorelaxation mechanism. Further force-tension myography tests in the mice tails demonstrated that vessels in mice that lacked Opn4 failed to display photorelaxation, which was also inhibited by an Opn4-specific small-molecule inhibitor.

The researchers also found that vasorelaxation is wavelength-specific, with a maximal response at about 430–460 nm. Blue light (455 nm) was found to regulate tail artery vasoreactivity ex vivo and tail blood blood flow in vivo, supporting a potential physiological role for this signaling system. The researchers also discovered that photorelaxation did not involve endothelial-, nitric oxide-, carbon monoxide-, or cytochrome p450-derived vasoactive prostanoid signaling, but was associated with vascular hyperpolarization. The study was published in the November 17, 2014, issue of Proceedings of the National Academy of Sciences of the United States of America (PNAS).

“If we can develop novel ways of delivering light to blood vessels, this molecular switch for relaxation could be harnessed in all types of vascular disease treatment,” said senior author Dan Berkowitz, MD, of the JHU departments of anesthesiology, critical care, and biomedical engineering. “We plan to use high-intensity light-emitting diodes (LEDs) incorporated into gloves as a potential mode of therapy for these patients. Additionally, socks with LEDs could be used in diabetic patients to potentially enhance blood flow and heal chronic ischemic ulcers.”

Melanopsin is also in found intrinsically photosensitive retinal ganglion cells, which do perceive light but are much slower to react to visual changes than the better-known rod and cone cells. They have been linked to a number of behavioral responses to light, including circadian photo-entrainment, light suppression of activity in nocturnal animals, and alertness in diurnal animals. Another type of melanopsin based receptor is involved in the association between light sensitivity and migraine pain.

Related Links:

Johns Hopkins University



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.